AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Burcon NutraScience Corporation

CAD 1.5 -$0.23 (-13.29%)
TSX · 15 Sep 2026 19:37 UTC
Previous Close
CAD 1.41
Day Range
CAD 1.5CAD 1.56
Year Range
CAD 1.3CAD 2.75
Market Cap
19.04M
AVG Volume
4.63K
Trailing/Forward PE
-1.32/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Toronto Stock ExchangeCA
Revenue (CAD)
0500K1M1.5M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Revenue (CAD) by quarter
PeriodRevenue (CAD)
27 Q11.28M
26 Q4826.19K
26 Q3739.1K
26 Q2357.19K
26 Q1342.19K
25 Q442.83K
25 Q361.49K
25 Q240.46K
25 Q1236.62K
24 Q40
Net Income (CAD)
-4M-3M-2M-1M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Net Income (CAD) by quarter
PeriodNet Income (CAD)
27 Q1-3.78M
26 Q4-3.6M
26 Q3-3.58M
26 Q2-3.59M
26 Q1-3.48M
25 Q4-2.26M
25 Q3-1.78M
25 Q2-2.35M
25 Q1-1.87M
24 Q4-2.07M
Operating Income (CAD)
-4M-3M-2M-1M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
27 Q1-3.15M
26 Q4-3.33M
26 Q3-2.67M
26 Q2-2.94M
26 Q1-2.48M
25 Q4-1.94M
25 Q3-1.79M
25 Q2-2.2M
25 Q1-1.76M
24 Q4-1.82M
EBITDA (CAD)
-3M-2M-1M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
27 Q1-2.45M
26 Q4-2.77M
26 Q3-1.93M
26 Q2-2.09M
26 Q1-2.41M
25 Q4-1.89M
25 Q3-1.72M
25 Q2-2.13M
25 Q1-1.7M
24 Q4-1.75M
Cash Flows (CAD)
-4M-3M-2M-1M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
27 Q1-2.43M
26 Q4-3.11M
26 Q3-1.72M
26 Q2-2.5M
26 Q1-2.82M
25 Q4-1.11M
25 Q3-1.47M
25 Q2-1.22M
25 Q1-2.02M
24 Q4-1.71M
EPS (CAD)
-0.3-0.2-0.1-024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO EPS (CAD) by quarter
PeriodEPS (CAD)
27 Q1-0.3
26 Q4-0.28
26 Q3-0.28
26 Q2-0.28
26 Q1-0.27
25 Q4-0.23
25 Q3-0.01
25 Q2-0.01
25 Q1-0.01
24 Q4-0.01
Expenses (CAD)
-1M01M2M3MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Expenses (CAD) by quarter
PeriodExpenses (CAD)
27 Q11.05M
26 Q4800.8K
26 Q31.06M
26 Q21.03M
26 Q11.26M
25 Q41.3M
25 Q31.69M
25 Q22.36M
25 Q11.99M
24 Q42.08M
Cash & Debt (CAD)
05M10M15M20MCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
27 Q1866.46K
26 Q4950.53K
26 Q31.29M
26 Q21.75M
26 Q14.23M
25 Q47.28M
25 Q3591.02K
25 Q21.04M
25 Q12.16M
24 Q44.2M
Debt ratios
-4-3-2-1024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Debt ratios by quarter
PeriodDebt ratios
27 Q1-3.04
26 Q4-2.55
26 Q3-2.76
26 Q2-2.64
26 Q1-2.21
25 Q4-2.03
25 Q3-0.99
25 Q2-0.79
25 Q1-0.7
24 Q4-0.4
Margins
-1500%-1000%-500%0%500%24 Q225 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Margins by quarter
PeriodMargins
27 Q1-168.62%
26 Q4-322.16%
26 Q3-306.06%
26 Q2-680.23%
26 Q1-419.21%
25 Q4-1283.5%
25 Q3-367.34%
25 Q2-295.35%
25 Q110.28%
24 Q2100%
Return on Capital
-4000%-2000%0%2000%4000%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Return on Capital by quarter
PeriodReturn on Capital
27 Q141.71%
26 Q462.08%
26 Q3143.81%
26 Q2-2782.79%
26 Q1-96.6%
25 Q4-32.5%
25 Q32169.22%
25 Q2-142.24%
25 Q1-53.58%
24 Q4-40.15%
Shares Outstanding
0100M200M300M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Shares Outstanding by quarter
PeriodShares Outstanding
27 Q112.69M
26 Q412.69M
26 Q312.69M
26 Q212.69M
26 Q112.69M
25 Q49.93M
25 Q3285.27M
25 Q2284.33M
25 Q1284.18M
24 Q4284.18M
Book Value Per Share (CAD)
-1-0.500.5124 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
27 Q1-0.71
26 Q4-0.46
26 Q3-0.2
26 Q20.01
26 Q10.28
25 Q40.7
25 Q3-0
25 Q20.01
25 Q10.01
24 Q40.02
Total Assets (CAD)
010M20M30M40M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
BU.TO Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
27 Q123.21M
26 Q422.99M
26 Q323.97M
26 Q224.55M
26 Q126.96M
25 Q430.66M
25 Q38.53M
25 Q29.57M
25 Q110.58M
24 Q412.91M
PE Ratio
0100000200000300000med 127523.67Jan 21Feb 21Mar 21Apr 21Apr 21May 21Jun 21
BU.TO PE Ratio by quarter
PeriodPE Ratio
Jun 21201530.49
Jun 21200458.52
Jun 21194562.68
Jun 21214394.14
May 21238513.48
May 21251377.13
May 21218146.04
May 21241193.41
Apr 21251913.11
Apr 21269600.63
Apr 21276032.46
Apr 21290504.06
Apr 21257808.95
Mar 2155551.92
Mar 2160484.65
Mar 2152850.67
Mar 2147213.26
Feb 2152498.33
Feb 2158840.41
Feb 2157783.39
Feb 2158370.62
Jan 2144042.22
Jan 2154142.57
Jan 2147800.49
Jan 2149444.73
Dec 2040401.4
Free Cash Flow Yield
-60%-40%-20%0%med -24.34%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BU.TO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-56.73%
Sep 26-53.69%
Sep 26-52.28%
Aug 26-50%
Aug 26-47.05%
Aug 26-40%
Aug 26-42.32%
Jul 26-44.44%
Jul 26-47.05%
Jul 26-43.01%
Jul 26-42.1%
Jul 26-40%
Jun 26-32.94%
Jun 26-29.2%
Jun 26-27.93%
Jun 26-32.44%
May 26-33.11%
May 26-31.96%
May 26-32.12%
May 26-31.33%
May 26-28.05%
Apr 26-28.55%
Apr 26-29.2%
Apr 26-28.93%
Apr 26-31.03%
Mar 26-32.78%
Mar 26-31.61%
Mar 26-28.97%
Mar 26-26.17%
Feb 26-26.39%
Feb 26-28.31%
Feb 26-31.3%
Feb 26-34.6%
Jan 26-32.1%
Jan 26-31.45%
Jan 26-36.63%
Jan 26-36.85%
Jan 26-36%
Dec 25-28.36%
Dec 25-29.48%
Dec 25-30.52%
Dec 25-31.06%
Nov 25-28.99%
Nov 25-28.99%
Nov 25-26.76%
Nov 25-22.49%
Oct 25-19.69%
Oct 25-22.59%
Oct 25-22.99%
Oct 25-23.3%
Oct 25-24.39%
Sep 25-24.4%
Sep 25-24.6%
Sep 25-25.24%
Sep 25-25.46%
Aug 25-22.35%
Aug 25-24.29%
Aug 25-21.45%
Aug 25-20.84%
Aug 25-20.54%
Jul 25-22.69%
Jul 25-19.52%
Jul 25-18.65%
Jul 25-17.69%
Jun 25-0.57%
Jun 25-0.71%
Jun 25-0.93%
Jun 25-1.07%
May 25-1.13%
May 25-1.07%
May 25-1.13%
May 25-1.13%
May 25-1.25%
Apr 25-1.25%
Apr 25-1.18%
Apr 25-1.32%
Apr 25-1.41%
Mar 25-1.2%
Mar 25-1.26%
Mar 25-1.26%
Mar 25-1.26%
Feb 25-1.34%
Feb 25-1.2%
Feb 25-1.14%
Feb 25-1.14%
Jan 25-1.2%
Jan 25-1.26%
Jan 25-1.42%
Jan 25-1.26%
Jan 25-1.42%
Dec 24-1.45%
Dec 24-1.45%
Dec 24-1.45%
Dec 24-1.37%
Nov 24-1.01%
Nov 24-0.86%
Nov 24-0.8%
Nov 24-0.9%
Nov 24-0.93%
Oct 24-0.86%
Price to Sales
01000200030004000med 60.31Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BU.TO Price to Sales by quarter
PeriodPrice to Sales
Sep 267.9
Sep 268.35
Sep 268.57
Aug 268.97
Aug 269.53
Aug 2611.21
Aug 2610.59
Jul 2610.09
Jul 269.53
Jul 2610.42
Jul 2610.65
Jul 2611.21
Jun 2616.71
Jun 2618.85
Jun 2619.7
Jun 2616.96
May 2616.62
May 2617.22
May 2617.13
May 2617.56
May 2619.62
Apr 2619.28
Apr 2618.85
Apr 2619.02
Apr 2617.73
Mar 2630
Mar 2631.1
Mar 2633.94
Mar 2637.57
Feb 2637.26
Feb 2634.73
Feb 2631.42
Feb 2628.42
Jan 2630.63
Jan 2631.26
Jan 2626.84
Jan 2626.68
Jan 2627.31
Dec 2547.94
Dec 2546.12
Dec 2544.55
Dec 2543.77
Nov 2546.9
Nov 2546.9
Nov 2550.81
Nov 2560.45
Oct 2569.05
Oct 2560.19
Oct 2559.14
Oct 2558.36
Oct 2555.76
Sep 2562.51
Sep 2561.99
Sep 2560.43
Sep 2559.91
Aug 2568.24
Aug 2562.77
Aug 2571.11
Aug 2573.19
Aug 2574.23
Jul 2567.2
Jul 2578.14
Jul 2581.79
Jul 2586.21
Jun 253328.22
Jun 252662.57
Jun 252039.06
Jun 251769.43
May 251685.17
May 251769.43
May 251685.17
May 251685.17
May 251516.66
Apr 251516.66
Apr 251600.91
Apr 251432.4
Apr 251348.14
Mar 251949.78
Mar 251847.16
Mar 251847.16
Mar 251847.16
Feb 251744.54
Feb 251949.78
Feb 252052.4
Feb 252052.4
Jan 251949.78
Jan 251847.16
Jan 251641.92
Jan 251847.16
Jan 251641.92
Dec 241080.09
Dec 241080.09
Dec 241080.09
Dec 241147.59
Nov 241552.63
Nov 241822.65
Nov 241957.66
Nov 241755.14
Nov 241687.64
Oct 241822.65
EV/EBITDA
500010000150002000025000med 14215.28Jan 21Feb 21Apr 21May 21Jul 21Aug 21Sep 21
BU.TO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2114174.04
Sep 2116122.92
Sep 2120368.68
Sep 2120786.3
Aug 2120716.7
Aug 2120020.67
Aug 2121064.71
Aug 2121969.55
Jul 2123988.02
Jul 2123222.39
Jul 2120855.9
Jul 2122665.57
Jul 2122387.16
Jun 2111992.24
Jun 2111928.4
Jun 2111577.29
Jun 2112758.31
May 2114194.7
May 2114960.77
May 2112981.75
May 2114354.3
Apr 2114992.69
Apr 2116046.04
Apr 2116429.07
Apr 2117290.9
Apr 2115343.81
Mar 2113055.34
Mar 2114215.28
Mar 2112420.14
Mar 2111094.49
Feb 2112337.28
Feb 2113828.63
Feb 2113580.07
Feb 2113718.16
Jan 2110348.81
Jan 2112723.93
Jan 2111232.58
Jan 2111619.22
Dec 209492.67
Price to Book
0200400600med 203.84Apr 24Jul 24Nov 24Feb 25Aug 25Dec 25Mar 26
BU.TO Price to Book by quarter
PeriodPrice to Book
Mar 26186.7
Mar 26193.58
Mar 26211.27
Mar 26233.87
Feb 26231.91
Feb 26216.18
Feb 26195.55
Feb 26176.88
Jan 26190.64
Jan 26194.57
Jan 26167.05
Jan 26166.07
Jan 26170
Dec 256.49
Dec 256.24
Dec 256.03
Dec 255.93
Nov 256.35
Nov 256.35
Nov 256.88
Nov 258.18
Oct 259.35
Oct 258.15
Oct 258.01
Oct 257.9
Oct 257.55
Sep 253.43
Sep 253.4
Sep 253.32
Sep 253.29
Aug 253.75
Aug 253.45
Aug 253.91
Aug 254.02
Aug 254.08
Jul 253.69
Jul 254.29
Jul 254.49
Jul 254.74
Mar 25326.3
Mar 25309.12
Mar 25309.12
Mar 25309.12
Feb 25291.95
Feb 25326.3
Feb 25343.47
Feb 25343.47
Jan 25326.3
Jan 25309.12
Jan 25274.78
Jan 25309.12
Jan 25274.78
Dec 24130.33
Dec 24130.33
Dec 24130.33
Dec 24138.48
Nov 24187.35
Nov 24219.93
Nov 24236.23
Nov 24211.79
Nov 24203.64
Oct 24219.93
Oct 24203.64
Oct 24244.37
Oct 24252.52
Sep 24187.49
Sep 24181.97
Sep 24198.51
Sep 24198.51
Aug 24164.33
Aug 24204.03
Aug 24209.54
Aug 24215.06
Aug 24204.03
Jul 24209.54
Jul 24226.09
Jul 24253.66
Jul 24248.14
Jun 24375.48
Jun 24366.75
Jun 24410.41
Jun 24445.34
May 24462.8
May 24480.27
May 24454.07
May 24445.34
May 24523.93
Apr 24427.87
Apr 24349.28
Apr 24427.87
Apr 24489
Mar 24314.86
Mar 24293.52
Mar 24229.48
Mar 24202.79
Mar 24213.47
Feb 24202.79
Feb 24218.8
Feb 24218.8
Feb 24197.46
Burcon NutraScience Corporation
BU.TO
Stockpicker

Video analysis: BU.TO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.